What Is It and Why We Do It
Clinical trial delays cost companies and investors millions of dollars in extra investment and foregone revenue. Over many years of conducting trials around the world, we see most trial delays are due to a single factor: Patient Enrollment Problems.
GDD Experts’ Patient Enrollment Assessment provides a pharmaceutical, biotech, or medical device company a blueprint for quickly bringing an additional 20, 50, 100, or 200 patients into your trial. Our free Assessment entails us conducting a feasibility analysis. By collecting data from specific Investigators in places such as India, SE Asia, Eastern Europe, Russia, Central and Latin America GDD Experts specifically assesses their qualifications and abilities to enroll patients that meet protocol requirements. We ensure that the trial can be undertaken at the highest level of quality and GCP adherence for FDA submission. We check what the standard of care is and, how many patients they see each month. We also collect information on how many trials they have completed or are currently working on. Upon confirming our ability to enroll the target number of patients, GDD Experts can be engaged to undertake the project.
For US-only trials, we can review protocol and study conduct details, and have our Project and Site Management experts determine possible causes of slow enrollment, then execute solutions to accelerate enrollment.
Benefits of GDD Experts’ Patient Enrollment Assessment
- No Charge to the client.
- Most Assessments completed within 1-Week because we work through our own people and proven partners.
- By bringing in more patients rapidly into a trial, we can Solve Your Patient Enrollment Problems.
- GDD Experts’ management has decades of experience designing and conducting clinical trials for large and small Pharmaceutical and Biotechnology clients, engaging with FDA and other global regulatory bodies, and representing CRO industry leadership groups with organizations such as DIA – so we deliver a World-class Quality Assessment you can act on.
- Each Assessment is Individually Crafted to meet your needs.
- We do not typically seek to displace the current CRO running a trial. Instead, we can Bolt-on a Patient Enrollment Component to an existing trial, and work in partnership with a CRO.
In most instances GDD Experts is contracted to undertake the enrollment project, the Cost to Client is usually a Net Zero. This is because: (i) by shortening clinical trial duration, trial cost is reduced, and (ii) a portion of GDD Experts’ compensation is tied to successful enrollment.
What We Need to Provide Patient Enrollment Assessment
- Signed CDA with company
- Study Protocol